Skip to main content Skip to main navigation menu Skip to site footer
PAGEPress
  • Bluesky
  • X
  • LinkedIn
MAP Kinase
  • Archives
  1. Home /
  2. Archives

Archives

4 issues published since 2012.

Current issue

Vol. 4 No. 1 (2015)

6 articles Published 22 October 2015

In this issue

  • JNK inhibitors: is there a future?
  • Clinical candidates of small molecule p38 MAPK inhibitors for inflammatory diseases
  • Expression of ERK1 and ERK2 in prostate cancer
  • Subversion of MAPK signaling by pathogenic bacteria
All 6 articles
Table of contents

Previous issues

  1. 2014

    The Biochemistry, Biology and Pathology of MAP Kinases II

    Vol. 3 No. s1 (2014)

    1 article Published 31 October 2014

    • The Biochemistry, Biology and Pathology of MAP Kinases II, 10-11 September 2014, Vilnius - Lithuania
  2. 2013

    Vol. 2 No. 1 (2013)

    5 articles Published 17 January 2013

    • Welcome to the incredible world of MAP Kinases
    • Control of the cell cycle progression by the MAPK Hog1
    • Mitogen-activated protein kinase signaling pathways of the tangerine pathotype of Alternaria alternata
    All 5 articles
  3. 2012

    Batsheva de Rothschild Seminar on Biochemistry, Biology and Pathology of MAP Kinases

    Vol. 1 No. s1 (2012)

    1 article Published 28 November 2012

    • Batsheva de Rothschild Seminar on Biochemistry, Biology and Pathology of MAP Kinases, 14-18 October 2012, Maale Hachamisha, Jerusalem Hills, Israel

Keywords

MAP Kinase

is an Open Access, peer-reviewed journal published by PAGEPress®, Pavia, Italy, in collaboration with MAP Kinase Resource, Bern, Switzerland. All credits and honors to PKP for their OJS.

eISSN 2235-4956

The journal

  • Archives
  • Announcements
  • Contact
  • Privacy Statement
PAGEPress

© PAGEPress 2008–2026. PAGEPress® is a registered trademark property of PAGEPress srl, Italy. VAT IT02125780185. This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.